@urineri.bsky.social will introduce the #RolyPoly - a python library for various common virus analysis tasks.
🍁Thur, October 8th, 8am London time. 🍁
Hosted by the RdRp Summit 2027 lead: @marcoforgia.bsky.social 🍁
All welcome! 😊
#RdRpSummit
@urineri.bsky.social will introduce the #RolyPoly - a python library for various common virus analysis tasks.
🍁Thur, October 8th, 8am London time. 🍁
Hosted by the RdRp Summit 2027 lead: @marcoforgia.bsky.social 🍁
All welcome! 😊
#RdRpSummit
#redm #redmroleplay #redmrp #RDRP #RDR2 #twitch #twitchstreamer #streamer
#redm #redmroleplay #redmrp #RDRP #RDR2 #twitch #twitchstreamer #streamer
🍁 September 25th, Fri at 14.00-15.00 Helsinki time.🍁
Hosted by one and only: @deminatanja.bsky.social
Everyone welcome to join! 😊 Check comment links!
#RdRpSummit #RNAVirusJournalClub
www.cell.com/molecular-th...
www.cell.com/molecular-th...
Here we construct an infectious clone and we go a little further in the understanding of their replication mechanism
doi.org/10.1126/scia...
Here we construct an infectious clone and we go a little further in the understanding of their replication mechanism
doi.org/10.1126/scia...
4/
4/
Thanks also to @psarkies.bsky.social @sebastianfalk.bsky.social Ralf Sommer, Falk Butter, @migueldvalmeida.bsky.social
link.springer.com/article/10.1...
Thanks also to @psarkies.bsky.social @sebastianfalk.bsky.social Ralf Sommer, Falk Butter, @migueldvalmeida.bsky.social
link.springer.com/article/10.1...
A dual antiviral and immune mechanism.
journals.asm.org/doi/10.1128/...
A dual antiviral and immune mechanism.
journals.asm.org/doi/10.1128/...
The grant will support reporting on a rural congregation in Forks, WA.
I'm excited to dig into rural religion—a part of Washington that doesn't get nearly enough religion reporting.
The grant will support reporting on a rural congregation in Forks, WA.
I'm excited to dig into rural religion—a part of Washington that doesn't get nearly enough religion reporting.
Inhaled siRNA SNS812 sped SARS-CoV-2 clearance, with antigen negativity at 2.9 vs 3.6 days.
It targets viral RdRP RNA.
No treatment-related adverse events.
link.springer.com/article/10.1...
Inhaled siRNA SNS812 sped SARS-CoV-2 clearance, with antigen negativity at 2.9 vs 3.6 days.
It targets viral RdRP RNA.
No treatment-related adverse events.
link.springer.com/article/10.1...
A recent @mdpiopenaccess.bsky.social study used alvaDesc descriptors to develop validated QSAR models for RSV L-RdRp inhibitors, screening over 15,000 compounds before docking, ADMET and MD simulations identified promising candidates. doi.org/10.3390/ph19...
A recent @mdpiopenaccess.bsky.social study used alvaDesc descriptors to develop validated QSAR models for RSV L-RdRp inhibitors, screening over 15,000 compounds before docking, ADMET and MD simulations identified promising candidates. doi.org/10.3390/ph19...